Genix Pharmaceuticals (TSXV:GENX) EV-to-FCF : -16.97 (As of Apr. 01, 2025)

Genix Pharmaceuticals EV-to-FCF Chart

Genix Pharmaceuticals Annual Data
	Trend	Oct15	Oct16	Oct17	Oct18	Oct19	Oct20	Oct21	Oct22	Oct23	Oct24
EV-to-FCF		Get a 7-Day Free Trial					-46.62	-20.55	-18.04	-12.98	-20.14

Genix Pharmaceuticals Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
EV-to-FCF	Get a 7-Day Free Trial															-12.98	-13.78	-16.80	-29.13	-20.14

Competitive Comparison of Genix Pharmaceuticals's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genix Pharmaceuticals's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's EV-to-FCF falls into.

Genix Pharmaceuticals EV-to-FCF Calculation

Genix Pharmaceuticals's EV-to-FCF for today is calculated as:

Genix Pharmaceuticals's current Enterprise Value is C$3.17 Mil.
Genix Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genix Pharmaceuticals  (TSXV:GENX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Genix Pharmaceuticals's PE Ratio (TTM) for today is calculated as:

Genix Pharmaceuticals's share price for today is C$0.04.
Genix Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Genix Pharmaceuticals EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Genix Pharmaceuticals Business Description